NewsRx

Search our medical news database

Alzheimer Disease

Alzheimer disease may be detected with blood-based test

Published in Biotech Business Week, March 13th, 2006

Norwegian life sciences company DiaGenic ASA (DIAG) announced that a second study confirmed its patented method to develop gene expression signatures using peripheral blood samples to detect Alzheimer disease.

DiaGenic ASA first announced findings from its pilot study in connection with the IPA's (International Psychogeriatric Association) 12th Congress on September 22, 2005. That study has now been reconfirmed with a larger study using Applied Biosystems microarray technology at the IMGM Laboratories in Germany.

"The results from the Alzheimer's study support DiaGenic's concept," said Are Aastveit, professor of Statistics, Norwegian University of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook